Frequently asked questions about Mpox (formerly Monkeypox disease) for hematopoietic cell transplantation and chimeric antigen receptor T cell recipients from the American Society for Transplantation and Cellular Therapy Review
| Authors: | Ford, E. S.; Papanicolaou, G. A.; Dadwal, S. S.; Pergam, S.; Spallone, A. |
| Review Title: | Frequently asked questions about Mpox (formerly Monkeypox disease) for hematopoietic cell transplantation and chimeric antigen receptor T cell recipients from the American Society for Transplantation and Cellular Therapy |
| Keywords: | review; drug efficacy; drug safety; nonhuman; polymerase chain reaction; t lymphocyte; t-lymphocytes; hematopoietic stem cell transplantation; disease severity; medical society; chimeric antigen receptor; cidofovir; biological therapy; immunocompromised patient; clinical outcome; smallpox vaccine; post exposure prophylaxis; humans; human; cell- and tissue-based therapy; patient risk; brincidofovir; chimeric antigen receptor t-cell immunotherapy; receptors, chimeric antigen; monkeypox; monkeypox vaccine; tecovirimat |
| Journal Title: | Transplantation and Cellular Therapy |
| Volume: | 29 |
| Issue: | 5 |
| ISSN: | 2666-6375 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2023-05-01 |
| Start Page: | 289 |
| End Page: | 292 |
| Language: | English |
| DOI: | 10.1016/j.jtct.2023.01.030 |
| PUBMED: | 36746374 |
| PROVIDER: | scopus |
| PMCID: | PMC9899127 |
| DOI/URL: | |
| Notes: | Review -- Export Date: 31 May 2023 -- Source: Scopus |
